Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era.
作者信息
Pasca Samantha, Zanon Ezio
机构信息
Haemophilia Centre, General Medicine, Padua University Hospital, Padua, Italy.
出版信息
Blood Transfus. 2021 Jan;19(1):73-76. doi: 10.2450/2020.0241-20. Epub 2020 Sep 18.
Abstract
摘要
相似文献
1
Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era.新冠疫情时代血友病治疗新疗法的利弊
Blood Transfus. 2021 Jan;19(1):73-76. doi: 10.2450/2020.0241-20. Epub 2020 Sep 18.
2
Thromboembolic Risks of Non-Factor Replacement Therapies in Hemophilia.血友病中非凝血因子替代疗法的血栓栓塞风险
Hamostaseologie. 2017;37(4):307-310. doi: 10.5482/20170004. Epub 2017 Dec 28.
3
Successful treatment of COVID-19 in a patient with severe haemophilia A on emicizumab prophylaxis in the intensive care unit.在重症监护病房中，一名接受emicizumab预防治疗的重度甲型血友病患者的新型冠状病毒肺炎得到成功治疗。
Haemophilia. 2021 Jul;27(4):e567-e570. doi: 10.1111/hae.14326. Epub 2021 Apr 29.
4
Therapeutic choices in persons with haemophilia at the time of COVID-19.新冠疫情期间血友病患者的治疗选择
Blood Transfus. 2020 Jul;18(4):326-327. doi: 10.2450/2020.0154-20.
5
Successful in-patient management of COVID-19 infection in an old severe haemophilia A patient on emicizumab with multiple prothrombotic comorbidities.在一名患有多种血栓形成合并症的老年重度甲型血友病患者中，使用emicizumab成功进行COVID-19感染的住院治疗。
Haemophilia. 2023 Mar;29(2):674-675. doi: 10.1111/hae.14743. Epub 2023 Jan 14.
6
The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.血友病治疗的发展：临床和实验室的进展、机遇和挑战。
Hamostaseologie. 2020 Aug;40(3):311-321. doi: 10.1055/a-1175-6530. Epub 2020 Jul 29.
7
New therapies using nonfactor products for patients with hemophilia and inhibitors.新型疗法使用非因子产品治疗血友病合并抑制物患者。
Blood. 2019 Jan 31;133(5):399-406. doi: 10.1182/blood-2018-07-820712. Epub 2018 Dec 17.
8
Management of COVID-19-associated coagulopathy in persons with haemophilia.COVID-19 相关凝血病的管理：血友病患者篇
Haemophilia. 2021 Jan;27(1):41-48. doi: 10.1111/hae.14191. Epub 2020 Nov 20.
9
Emerging Therapeutic Strategies in the Treatment of Hemophilia A.治疗甲型血友病的新兴治疗策略
Semin Thromb Hemost. 2017 Sep;43(6):581-590. doi: 10.1055/s-0037-1604053. Epub 2017 Jul 27.
10
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.直面新冠疫情：血友病和先天性出血性疾病相关问题
Semin Thromb Hemost. 2020 Oct;46(7):819-822. doi: 10.1055/s-0040-1712961. Epub 2020 Jun 8.
本文引用的文献
1
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
2
Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis.2019年冠状病毒病大流行对血栓形成-止血治疗选择的影响。
J Thromb Haemost. 2020 Jul;18(7):1794-1795. doi: 10.1111/jth.14845. Epub 2020 May 11.
3
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常凝血参数与新型冠状病毒肺炎患者的不良预后相关。
J Thromb Haemost. 2020 May;18(5):1233-1234. doi: 10.1111/jth.14820.
4
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
5
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.严重新型冠状病毒肺炎与非新型冠状病毒肺炎患者凝血功能特征的差异。
J Thromb Thrombolysis. 2021 May;51(4):1107-1110. doi: 10.1007/s11239-020-02105-8.
6
Clinical findings in a patient with haemophilia A affected by COVID-19.一名甲型血友病患者感染新型冠状病毒肺炎的临床发现。
Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13.
7
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.COVID-19 的病毒学、流行病学、发病机制和防控。
Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372.
8
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia.2019新型冠状病毒肺炎患者的弥散性血管内凝血
J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.
9
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
10
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.皮下康西珠单抗预防治疗 A 型血友病和有抑制剂的 A/B 型血友病：2 期临床试验结果。
Blood. 2019 Nov 28;134(22):1973-1982. doi: 10.1182/blood.2019001542.
Zotero 插件